LVM Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.5M Buy
172,974
+1,505
+0.9% +$324K 3.64% 8
2026
Q1
$37.3M Buy
171,469
+1,758
+1% +$390K 3.52% 7
2025
Q4
$38.8M Buy
169,711
+47
+0% +$10.7K 3.6% 6
2025
Q3
$39.3M Buy
169,664
+2,326
+1% +$474K 3.78% 5
2025
Q2
$31.1M Buy
167,338
+1,211
+0.7% +$225K 3.22% 5
2025
Q1
$34.8M Buy
166,127
+2,854
+2% +$555K 3.88% 5
2024
Q4
$29M Buy
163,273
+6,892
+4% +$1.27M 3.12% 6
2024
Q3
$26.8M Hold
156,381
3.05% 7
2024
Q2
$26.8M Sell
156,381
-1,861
-1% -$308K 3.05% 7
2024
Q1
$28.8M Sell
158,242
-127
-0.1% -$21.9K 3.4% 6
2023
Q4
$24.5M Buy
158,369
+3,059
+2% +$446K 3.14% 5
2023
Q3
$23.2M Sell
155,310
-1,070
-0.7% -$157K 3.26% 6
2023
Q2
$21.1M Sell
156,380
-1,051
-0.7% -$154K 2.82% 7
2023
Q1
$25.1M Sell
157,431
-367
-0.2% -$56.1K 3.48% 6
2022
Q4
$25.5M Sell
157,798
-4,155
-3% -$637K 3.7% 4
2022
Q3
$21.7M Sell
161,953
-1,282
-0.8% -$184K 3.33% 5
2022
Q2
$25M Buy
163,235
+130
+0.1% +$19.9K 3.63% 4
2022
Q1
$26.4M Sell
163,105
-11,114
-6% -$1.61M 3.49% 4
2021
Q4
$23.6M Sell
174,219
-15,393
-8% -$1.82M 3.14% 6
2021
Q3
$20.5M Sell
189,612
-5,086
-3% -$581K 3.08% 6
2021
Q2
$21.9M Buy
194,698
+115
+0.1% +$13K 3.35% 5
2021
Q1
$21.1M Sell
194,583
-14,089
-7% -$1.51M 3.42% 5
2020
Q4
$22.4M Sell
208,672
-364
-0.2% -$35K 3.77% 4
2020
Q3
$18.3M Buy
209,036
+1,528
+0.7% +$144K 3.55% 5
2020
Q2
$20.4M Sell
207,508
-3,487
-2% -$307K 4.18% 3
2020
Q1
$16.1M Sell
210,995
-90
-0% -$7.67K 3.96% 3
2019
Q4
$18.7M Buy
211,085
+3,920
+2% +$325K 3.69% 4
2019
Q3
$15.7M Buy
207,165
+12,200
+6% +$836K 3.33% 7
2019
Q2
$14.2M Buy
194,965
+13,070
+7% +$1.03M 3.23% 7
2019
Q1
$14.7M Buy
181,895
+3,288
+2% +$269K 3.36% 8
2018
Q4
$16.5M Buy
178,607
+4,836
+3% +$425K 4.31% 6
2018
Q3
$16.4M Sell
173,771
-1,220
-0.7% -$116K 3.75% 7
2018
Q2
$16.2M Buy
174,991
+3,031
+2% +$296K 3.91% 6
2018
Q1
$16.3M Sell
171,960
-1,990
-1% -$219K 3.75% 7
2017
Q4
$16.8M Sell
173,950
-265
-0.2% -$25K 3.81% 6
2017
Q3
$15.5M Sell
174,215
-34,400
-16% -$2.62M 3.7% 6
2017
Q2
$15.1M Buy
208,615
+2,135
+1% +$144K 3.86% 6
2017
Q1
$13.5M Buy
206,480
+2,725
+1% +$171K 3.46% 8
2016
Q4
$12.8M Buy
203,755
+47,427
+30% +$2.89M 3.53% 8
2016
Q3
$8.82M Sell
156,328
-43,627
-22% -$2.82M 2.84% 14
2016
Q2
$12.4M Buy
199,955
+2,305
+1% +$140K 3.58% 7
2016
Q1
$11.3M Buy
197,650
+15,000
+8% +$836K 3.58% 9
2015
Q4
$10.8M Buy
182,650
+3,260
+2% +$188K 3.82% 7
2015
Q3
$9.76M Buy
179,390
+29,019
+19% +$1.89M 3.52% 8
2015
Q2
$10.1M Buy
150,371
+252
+0.2% +$16.5K 3.37% 7
2015
Q1
$8.79M Buy
150,119
+3,770
+3% +$228K 2.94% 14
2014
Q4
$9.58M Sell
146,349
-4,947
-3% -$312K 3.18% 12
2014
Q3
$8.74M Sell
151,296
-5,032
-3% -$279K 2.87% 13
2014
Q2
$8.82M Sell
156,328
-264
-0.2% -$13.8K 2.84% 14
2014
Q1
$8.05M Buy
156,592
+4,900
+3% +$248K 2.81% 14
2013
Q4
$8.01M Sell
151,692
-163
-0.1% -$8.01K 2.84% 13
2013
Q3
$6.79M Buy
151,855
+17,035
+13% +$755K 2.55% 15
2013
Q2
$5.57M Buy
+134,820
New +$5.9M 2.22% 20

Other funds holding ABBV

LVM Capital Management's ABBV Position: Q2 2026 in Review

LVM Capital Management increased its AbbVie (ABBV) stake by 0.88% in Q2 2026, buying an estimated $324K and bringing the position to 172,974 shares worth $43.5M. The position accounts for 3.64% of the portfolio, ranked #8.

LVM Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LVM Capital Management held 172,974 shares of AbbVie worth $43.5M as of Q2 2026.
  • LVM Capital Management bought 1,505 AbbVie shares in Q2 2026, an estimated $324K.
  • AbbVie made up 3.64% of LVM Capital Management's portfolio in Q2 2026, its #8 holding.
  • LVM Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.